FY26 Results: Profit Skyrockets 636% & Dividend Declared
Tatva Chintan Pharma Chem Ltd · TATVA · BSE ·
**Profit Explosion**: Profit After Tax (PAT) for FY26 surged by **636%** to ₹42.05 Crores compared to the previous year. **Strong Revenue Growth**: Revenue from Operations grew by **32%** year-over-year to ₹505.86 Crores. **Dividend Recommended**: The Board has recommended a fina…